AOBiome Therapeutics is a clinical-stage therapeutics company addressing a broad range of inflammatory conditions by harnessing a single strain of class defining Ammonia Oxidizing Bacteria (AOB).
AOBiome, LLC
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.aobiome.com
Disease Focus
STOCK CODENon Listed
Address125 Cambridgepark Drive, MA 02140CambridgeUnited States
125 Cambridgepark Drive, MA 02140
Cambridge
United States
Contact Number+1 617-639-9980
+1 617-639-9980
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/aobiome” connections=”true” suffix=””]